Aminoglycosides are a class of antibiotics used mainly to treat serious infections in a clinical setting.

Aminoglycosides are a class of antibiotics utilized against certain types of bacteria, specifically Gram-negative infections. 22 The most common aminoglycoside used in the NICU is gentamicin 23 ...

Choosing the appropriate antibiotics to treat bacterial infections has grown more challenging because of the emergence of antibiotic-resistant bacteria. Aminoglycosides, as broad-spectrum ...

The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers.

An expert briefly describes the study ‘Single Dose Aminoglycosides versus Carbapenems for the Treatment of Uncomplicated Urinary Tract Infections Caused by Extended-Spectrum β-lactamase ...

Spatial- and time-resolution FRET methods on single pre-translocation ribosome complexes reveal that aminoglycoside antibiotics inhibit translocation by altering structural and dynamic parameters ...

According to Market.us, the market size for aminoglycosides is expected to experience significant growth, with projections indicating an increase from a valuation of USD 1.8 billion in 2023 to ...

Two primary resistance mechanisms—aminoglycoside enzymatic modification and 16S rRNA methylation—were assessed, and the prevalence of the corresponding ARGs was described.

Antibiotic consumption is currently not the main driver of aminoglycoside resistance spread, study suggests Drug resistance to aminoglycosides, a class of antibiotics, may be driven more by ...

Sanofi has taken in-house an early-stage antibiotics program developed by its partner Warp Drive Bio. The novel aminoglycosides were discovered using Warp Drive’s genome mining technology, which ...

The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers. In these diseases, a mutation in the genetic code ...

The spread of antibiotic resistance, whereby infectious bacteria are able to defeat the drugs intended to kill them, may not be primarily driven by antibiotic consumption, according to a study ...